Evidence map›Paper›PMID 35462903›Full record

ReviewFrontiers in pharmacology2022

Application of Quercetin in the Treatment of Gastrointestinal Cancers.

Seyed Mohammad Ali Mirazimi, Fatemeh Dashti, Mohammad Tobeiha, Ali Shahini, Raha Jafari, Mehrad Khoddami, Amir Hossein Sheida, Parastoo EsnaAshari, Amir Hossein Aflatoonian, Fateme Elikaii and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Antitumor components and mechanisms ofFrontiers in pharmacology · 2025
    Review
  11. Review
  12. Current computer-aided drug design · 2025
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Seyed Mohammad Ali MirazimiSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Fatemeh DashtiSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Mohammad TobeihaSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Ali ShahiniFaculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Raha JafariDepartment of Medicine, Mashhad Medical Sciences Branch, Islamic Azad University, Mashhad, Iran.
Mehrad KhoddamiResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Amir Hossein SheidaSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Parastoo EsnaAshariSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Amir Hossein AflatoonianSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Fateme ElikaiiSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Melika Sadat ZakeriSchool of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Michael R HamblinLaser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, South Africa.
Mohammad AghajaniInfectious Disease Research Center, School of Nursing and Midwifery, Kashan University of Medical Sciences, Kashan, Iran.
Minoodokht BavarsadkarimiClinical Research Development Center, Mahdiyeh Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamed MirzaeiResearch Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Kashan University of Medical Sciences · IRIslamic Azad University, Mashhad · IRMashhad University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRUniversity of Johannesburg · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many cellular signaling pathways contribute to the regulation of cell proliferation, division, motility, and apoptosis. Deregulation of these pathways contributes to tumor cell initiation and tumor progression. Lately, significant attention has been focused on the use of natural products as a promising strategy in cancer treatment. Quercetin is a natural flavonol compound widely present in commonly consumed foods. Quercetin has shown significant inhibitory effects on tumor progression

Indexed as

bioactive compoundsgastrointestinal cancersnatural compoundsquercetintherapy

Identifiers

PMID35462903
PMCPMC9019477
OpenAlexW4226082398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.